These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8143368)

  • 1. Immunonephelometric/turbidimetric apolipoprotein B assays for the clinical laboratory.
    Levinson SS; Wagner SG
    Clin Chim Acta; 1993 Dec; 223(1-2):31-42. PubMed ID: 8143368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a turbidimetric procedure for apolipoproteins A1 and B on the Ciba Corning 550 EXPRESS.
    Nazir DJ; Mori L; Padala VR; Wright R; McQueen MJ
    Clin Biochem; 1993 Dec; 26(6):477-82. PubMed ID: 8124863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative usefulness of automated apolipoprotein A-I and high-density lipoprotein cholesterol assays as markers for coronary artery disease.
    Levinson SS; Wagner SG
    Am J Clin Pathol; 1994 Jan; 101(1):104-8. PubMed ID: 8279444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of human apolipoproteins A-I, B, and E by laser nephelometry.
    Weisweiler P; Schwandt P
    J Clin Chem Clin Biochem; 1984 Jan; 22(1):113-8. PubMed ID: 6421988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
    Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
    Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between apolipoprotein B-100 and low-density lipoprotein cholesterol after treatment with an HMG CoA reductase inhibitor.
    Levinson SS; Blevins RD; Smith MP; Rubinfire M; Maciejko JJ
    Am J Clin Pathol; 1989 Oct; 92(4):479-83. PubMed ID: 2508466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion.
    Mendoza SG; Zerpa A; Carrasco H; Colmenares O; Rangel A; Gartside PS; Kashyap ML
    Artery; 1983; 12(1):1-23. PubMed ID: 6431945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients.
    Wägner AM; Pérez A; Calvo F; Bonet R; Castellví A; Ordóñez J
    Diabetes Care; 1999 May; 22(5):812-7. PubMed ID: 10332687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanized lipoprotein(a) assay as a marker for coronary artery disease illustrates the usefulness of high lipoprotein(a) levels.
    Hobbs GA; Kaplan IV; Levinson SS
    Clin Chim Acta; 1998 Jun; 274(1):1-13. PubMed ID: 9681593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial.
    Sacks FM; Alaupovic P; Moye LA; Cole TG; Sussex B; Stampfer MJ; Pfeffer MA; Braunwald E
    Circulation; 2000 Oct; 102(16):1886-92. PubMed ID: 11034934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipid pattern as severity indicator of angiographically assessed coronary artery disease.
    Uccella R; Donnini P; Franzetti I; Gaiazzi M
    Artery; 1993; 20(6):346-60. PubMed ID: 8010890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL molecular size as risk factor in coronary artery disease.
    Kozma L; Fodor J; Chockalingam A; Sussex B
    Acta Med Hung; 1992-1993; 49(1-2):65-77. PubMed ID: 1296188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of the analysis of lipoproteins after myocardial infarction].
    Dewailly P; Mellin D; Moulin S; Rouget JP; Sezille G; Jaillard J
    Presse Med; 1983 Jul 9-16; 12(29):1807-10. PubMed ID: 6224195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter evaluation of automated immunoturbidimetric assays for measurement of apolipoproteins A-I and B in serum and plasma.
    Kahn SE; Labbé RF; Pfadenhauer EH; Kanonchoff AD; Joseph RT
    Clin Chem; 1994 Sep; 40(9):1722-9. PubMed ID: 8070082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipids and apolipoproteins A-I, A-II, and B in hyperthyroidism before and after treatment.
    Muls E; Blaton V; Rosseneu M; Lesaffre E; Lamberigts G; De Moor P
    J Clin Endocrinol Metab; 1982 Sep; 55(3):459-64. PubMed ID: 6808006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated determination of apolipoproteins A-I and B with an improved immunoturbidimetric assay using Boehringer Mannheim and Hitachi analyzer systems.
    Borque L; Maside C; Rus A; del Cura J
    Clin Biochem; 1993 Dec; 26(6):471-6. PubMed ID: 8124862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is increased apolipoprotein B-A major factor enhancing the risk of coronary artery disease in type 2 diabetes?
    Snehalatha C; Ramachandran A; Sivasankari S; Satyavani K; Viswanathan V; Misra J; Girinath MR; Sathyamurthy I
    J Assoc Physicians India; 2002 Aug; 50():1036-8. PubMed ID: 12421026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein B: novel indicator of elevated intraocular pressure.
    Son JH; Chung YK; Son JS
    Eye (Lond); 2015 Oct; 29(10):1315-20. PubMed ID: 25853444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoproteins: correlation with carotid intimamedia thickness and coronary artery disease.
    Jadhav UM; Kadam NN
    J Assoc Physicians India; 2004 May; 52():370-5. PubMed ID: 15656025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.